Results 211 to 220 of about 3,146,543 (345)

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

open access: yesMolecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu   +18 more
wiley   +1 more source

High Seroprevalence of <i>Helicobacter pylori</i> and CagA/VacA Virulence Factors in Northern Central America. [PDF]

open access: yesGastroenterology Res
Corral JE   +10 more
europepmc   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Triple-target radiosurgery for intractable cancer pain of mixed origin: Two-centre experience in Central America. [PDF]

open access: yesBr J Pain
Del Cid P   +8 more
europepmc   +1 more source

A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central America. [PDF]

open access: yesBlood Adv, 2023
Rangel-Patiño J   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy